Glycolytic Signaling Pathways and Anti-Glycolytic Therapy for Cancer: Research and Perspectives

Area of Science:

• Oncology
• Cancer Metabolism
• Biochemistry

Background:

• The Warburg effect describes enhanced glycolysis and lactate production in cancer cells, even with oxygen.
• This metabolic shift supports tumor cell energy and biosynthesis demands.
• It plays a crucial role in tumor progression and therapeutic resistance.

Purpose of the Study:

• To review key regulators of glycolytic signaling pathways in cancer.
• To examine the interplay between glycolysis, oxidative phosphorylation (OXPHOS), and fatty acid metabolism.
• To highlight the role of intravital imaging in studying tumor metabolism and discuss targeted therapies.

Main Methods:

• Literature review synthesizing current research on the Warburg effect.
• Analysis of signaling pathways regulating glycolysis in tumors.
• Examination of intravital imaging techniques for metabolic studies.
• Review of clinical progress for glycolysis inhibitors and combination therapies.

Main Results:

• Glycolysis is central to the tumor metabolic network, driving energy and biosynthesis.
• Metabolic reprogramming contributes to resistance against chemotherapy and radiotherapy.
• Intravital imaging offers real-time insights into metabolic alterations in vivo.
• Glycolysis inhibitors show clinical potential, with ongoing research into combination strategies.

Conclusions:

• Targeting the Warburg effect and tumor metabolic reprogramming is a promising therapeutic strategy.
• Combining metabolic interventions with immunotherapy and other treatments may overcome resistance.
• Further research into glycolysis inhibitors and novel metabolic approaches is warranted for precision oncology.